Literature DB >> 29164429

Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis.

Jiuliang Zhao1, Hongnan Mo1, Xiaoxiao Guo2, Qian Wang1, Dong Xu1, Yong Hou1, Zhuang Tian2, Yongtai Liu2, Hui Wang2, Jinzhi Lai2, Mengtao Li1, Xiaofeng Zeng3.   

Abstract

The aim of this study was to investigate the utility of red blood cell distribution width (RDW) as a simple and readily available marker of occurrence of pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc). One hundred and forty-five consecutive patients with SSc were recruited to the single-center cross-sectional study. Demographic characteristics, hematological parameters, Modified Rodnan Skin Score, and World Health Organization functional classification were determined. Diagnosis of PAH was based on screening by echocardiography and was confirmed by right heart catheterization. Interstitial lung disease (ILD) was diagnosed based on chest high-resolution computed tomography findings. There were no significant differences in gender, age, or disease duration between limited and diffused SSc groups. PAH was detected in 28 of lcSSc (33.3%) and 14 of dcSSc (23.0%) subjects. Patients with higher RDW values were more likely to be men with high anti-u1RNP titers and PAH. A significant correlation was found between RDW and high-sensitivity C-reactive protein (p = 0.375, p < 0.01) and the diffusing capacity of the lungs for carbon monoxide (ρ = - 0.396, p < 0.01). The SSc-PAH group had significantly higher RDW values compared to the SSc group without pulmonary disease (15.7 ± 2.2 and 13.7 ± 1.0, p < 0.001). The mean RDW in the SSc-PAH-ILD group was significantly higher than that in the SSc-ILD group (16.3 ± 2.2% and 14.0 ± 1.5%, p < 0.001). Besides the recognized risk factors, high RDW was an independent predictor of PAH in patients with SSc (OR = 3.314 [95%CI 1.038-10.580], p < 0.05). RDW may be a related factor for identifying the pulmonary arterial hypertension in SSc patients.

Entities:  

Keywords:  Inflammation; Pulmonary arterial hypertension; Red blood cell distribution width; Systemic sclerosis

Mesh:

Substances:

Year:  2017        PMID: 29164429     DOI: 10.1007/s10067-017-3918-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  High resolution computed tomography as a predictor of lung histology in systemic sclerosis.

Authors:  A U Wells; D M Hansell; B Corrin; N K Harrison; P Goldstraw; C M Black; R M du Bois
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

4.  Determinants of pulmonary arterial hypertension in scleroderma.

Authors:  Sotiris C Plastiras; Stylianos P Karadimitrakis; Christos Kampolis; Haralampos M Moutsopoulos; George E Tzelepis
Journal:  Semin Arthritis Rheum       Date:  2007-01-03       Impact factor: 5.532

Review 5.  Pulmonary arterial hypertension in systemic sclerosis.

Authors:  Sevdalina Lambova; Ulf Müller-Ladner
Journal:  Autoimmun Rev       Date:  2010-06-23       Impact factor: 9.754

6.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

7.  Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.

Authors:  Chetan V Hampole; Amit K Mehrotra; Thenappan Thenappan; Mardi Gomberg-Maitland; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2009-09-15       Impact factor: 2.778

8.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

9.  Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.

Authors:  G Michael Felker; Larry A Allen; Stuart J Pocock; Linda K Shaw; John J V McMurray; Marc A Pfeffer; Karl Swedberg; Duolao Wang; Salim Yusuf; Eric L Michelson; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

10.  Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.

Authors:  Dinesh Khanna; Vivek Nagaraja; Chi-Hong Tseng; Fereidoun Abtin; Robert Suh; Grace Kim; Athol Wells; Daniel E Furst; Philip J Clements; Michael D Roth; Donald P Tashkin; Jonathan Goldin
Journal:  Arthritis Res Ther       Date:  2015-12-23       Impact factor: 5.156

View more
  8 in total

1.  Use of red cell distribution width in a population at high risk for pulmonary hypertension.

Authors:  Laura A Petrauskas; Lesley Ann Saketkoo; Thomas Kazecki; Shigeki Saito; Vijay Jaligam; Bennett P deBoisblanc; Matthew R Lammi
Journal:  Respir Med       Date:  2019-03-16       Impact factor: 3.415

2.  Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.

Authors:  Min Hui; Jiuliang Zhao; Zhuang Tian; Jieying Wang; Junyan Qian; Xiaoxi Yang; Qian Wang; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2018-09-14       Impact factor: 2.980

3.  A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: Red cell distribution width-to-platelet ratio.

Authors:  Buse Özer Bekmez; Cüneyt Tayman; Mehmet Büyüktiryaki; Aslıhan Köse Çetinkaya; Ufuk Çakır; Turan Derme
Journal:  J Clin Lab Anal       Date:  2018-07-06       Impact factor: 2.352

Review 4.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

Review 5.  A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension.

Authors:  A Josien Smits; Liza Botros; Marijke A E Mol; Kirsten A Ziesemer; Martin R Wilkins; Anton Vonk Noordegraaf; Harm Jan Bogaard; Jurjan Aman
Journal:  ERJ Open Res       Date:  2022-05-30

6.  Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders.

Authors:  Mattia Bellan; Ailia Giubertoni; Cristina Piccinino; Arnaldo Dimagli; Federico Grimoldi; Maurizio Sguazzotti; Michela Emma Burlone; Carlo Smirne; Daniele Sola; Paolo Marino; Mario Pirisi; Pier Paolo Sainaghi
Journal:  Dis Markers       Date:  2019-06-02       Impact factor: 3.434

7.  Prognostic impact of red blood cell distribution width in pulmonary hypertension patients: A systematic review and meta-analysis.

Authors:  Jie Liu; Jiao Yang; Shuanglan Xu; Yun Zhu; Shuangyan Xu; Li Wei; Panpan Qian; Yuanyuan Lv; Chunfang Zhang; Xiqian Xing; Yishu Deng
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

8.  Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study.

Authors:  Satoshi Ebata; Ayumi Yoshizaki; Takemichi Fukasawa; Asako Yoshizaki-Ogawa; Yoshihide Asano; Kosuke Kashiwabara; Koji Oba; Shinichi Sato
Journal:  Diagnostics (Basel)       Date:  2021-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.